Search

The aim of the research was to implement an athletic program to improve the explosive force in order to optimize physical fitness at the level of elite football-tennis players and evaluate the progress made through specific tests using the Opto Jump. The research included 10 elite European and world-class players, on whom an experimental program was applied in order to improve the explosive force of the limbs in conditions of speed, endurance, and dynamic balance. Study tests: five vertical jumps on the spot, on the left/right leg; five back and forth jumps on the left/right leg; five left/right side jumps on the left/right leg; vertical jumps on both legs 60 s; BFS vertical jumps. For each test, the following parameters specific to the explosive force were statistically analyzed: contact time (s); flight time (s); jump height (cm), jump power (w/kg); RSI-Reactive Strength Index, defined as Height (m/s). In the study, the average value of the parameters specific to the jumps performed in each test was taken into account. During the study, the tests were performed and processed on the Opto Jump device and software. In all tests of the experiment monitored through Opto Jump, significant progress was made in the final test compared to the initial one, which demonstrates the efficiency of the physical training program implemented for the development of explosive force, with an impact on the sports performance of elite players. The most relevant results obtained for the left leg regarding the improvement of the explosive force of the lower limbs materialized in the jump height parameter was in the test of five vertical jumps on one leg on the spot, and for the right leg in the tests of: five back and forth jumps and five left/right side jumps. The most significant advances in the study were in the tests, in descending order of their weight: 60 s vertical jumps on both legs; five back-and-forth jumps and five left/right side jumps, five vertical jumps on one leg standing, and BFS vertical jumps., Competing Interests: The authors declare no conflict of interest.

Arterial and venous thrombosis are the most frequent complications in patients with polycythemia vera and essential thrombocythemia. We sought to demonstrate a possible contribution of the factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) 677 C > T and 1298 A > C mutations to the thrombotic risk in patients with polycythemia vera and essential thrombocythemia along with other biological features of these patients. We included 86 patients with polycythemia vera, of which 34 (39.5 %) had major thrombosis and 95 patients with essential thrombocythemia, of which 22 (23.1 %) had major thrombosis. In the whole cohort of patients, only the factor V Leiden mutation was significantly associated with both arterial and venous thrombosis in univariate and multivariate analysis (odds ratio (OR) = 4.3; 95 % confidence interval (CI) = 1.5-12.5; p = 0.008 and OR = 4.3; 95 % CI = 1.2-15.9; p = 0.02, respectively). Other factors significantly associated with thrombosis in both univariate and multivariate analysis were male sex (OR = 2.8, 95 % CI = 1.4-5.4, p = 0.002 and OR = 3.5, 95 % CI = 1.6-7.6, p = 0.002, respectively) and the JAK2 V617F mutation (OR = 5.5, 95 % CI = 2.1-15, p = 0.0001 and OR = 6.9, 95 % CI = 2.2-21.2, p = 0.001, respectively). In conclusion, among the four mutations analyzed (factor V Leiden, prothrombin G20210A, and MTHFR 677 C > T and 1298 A > C), only factor V Leiden is a major contributor to thrombosis in polycythemia vera and essential thrombocythemia.